HOME Top Market Reports In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023

In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023

By: marketsandmarkets.com
Publishing Date: April 2018
Report Code: BT 6203

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


Lung in vitro models are defined as cell models that represent a normal or diseased lung physiology. These cells when constructed in a monolayer on a petri plate are called 2D in vitro models. 3D models have a 3-dimensional architecture and use supports and scaffolds to maintain their structure. 3D models can be made in-house using consumables and are also available commercially as ready-to-use in vitro models.

The global in vitro lung model market was valued at USD 166.5 Million in 2017 and is expected to reach USD 427.4 Million by 2023, at a CAGR of 17.5% during the forecast period.

The base year considered for this report is 2017, while 2018-2023 is the forecast period.

Objectives of the Study

  • To define, describe, and forecast the lung in vitro models by type, application, and region
  • To provide detailed information about factors influencing market growth (drivers, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and details of the competitive landscape for market leaders
  • To forecast the size of in vitro lung model market segments with respect to the four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To profile key players and comprehensively analyze their core competencies in terms of key market developments, product portfolios, and financials
  • To track and analyze competitive developments such as acquisitions; product developments; partnerships, agreements, and collaborations; and expansions in the laboratory automation market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the in vitro lung model market and estimate the size of other dependent submarkets. Various secondary sources such as the American Lung Association, National Center for Biotechnology Information, National Centre for Advancing Translational Sciences, European Union Reference Laboratory for alternatives to animal testing (EURL-ECVAM), European Lung Foundation, Annual Reports, Presentations, Press Releases, Journals, Paid Databases, have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

In Vitro Lung Model Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the in vitro lung model market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

Target Audience:

  • Biotechnology companies that are into tissue engineering and development of 3D in vitro models
  • Pharmaceutical industries
  • Academic and government research institutes
  • Contract research organizations (CROs)
  • Venture capitalists and investors

Scope of the Report:

The research report categorizes the in vitro lung model market into the following segments and subsegments:

  • Lung In Vitro Models Market, By Type

    • 2D Models
    • 3D Models
      • In-house 3D Models
      • Commercialized 3D Models
  • Lung In Vitro Models Market, By Application

    • Applications of 2D Models
      • Drug Discovery and Toxicology
      • 3D Model Development
      • Basic Research
    • Applications of 3D Models
      • Drug Discovery and Toxicology
      • Physiological Research
      • Stem Cell Research and Regenerative Medicine
  • Lung In Vitro Models Market, By Region

    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction
    1.1 Market Definition
    1.2 Currency
    1.3 Limitations
    1.4 Assumptions for the Study
    1.5 Years Considered for the Study
    1.6 Segmentation

2 Research Methodology
    2.1 Research Design
    2.2 Primary Research
    2.3 Bottom Up Approach
    2.4 Top Down Approach
    2.5 Market Breakdown

3 Executive Summary

4 Market Dynamic
    4.1 Market Overview
    4.2 Drivers
           4.2.1  Growing Focus on Developing Alternatives for Animal Testing Models
           4.2.2 Technological Advancements and the Development of New 3D In Vitro Models
           4.2.3 Significant Increase in Research Funding and Venture Capital Investments
    4.3 Opportunities
           4.3.1 Increasing Number of Drug Discovery Activities
           4.3.2 Applications in Regenerative Medicine, Tissue Engineering, and Oncology Research
    4.4 Challenges
           4.4.1 Dearth of Skilled Professionals

5 In Vitro Lung Model Market, By Type
    5.1 Introduction
    5.2 2D Cell Models
    5.3 3D Cell Models
           5.3.1 Commercial 3D Cell Models
           5.3.2 Inhouse 3D Cell Models

6 In Vitro Lung Model Market, By Application
    6.1 Introduction
    6.2 Applications of 2D Models
    6.3 Applications of 3D Models

7 In Vitro Lung Model Market, By Region
    7.1 Introduction
    7.2 North America
    7.3 Europe
    7.4 APAC
    7.5 RoW

8 Competitive Landscape
    8.1 Market Overview
    8.2 Market Evolution Framework
    8.3 Market Ranking Analysis
    8.4 Competetive Situations and Trends
           8.4.1 Agreements, Partnerships, and Collaborations
           8.4.2 Product Launches and Upgrades
           8.4.3 Expansions

9 Company Profiles
    9.1 Atcc
    9.2 Lonza
    9.3 Epithelix
    9.4 Mattek
    9.5 Emulate
    9.6 Tissuse
    9.7 Mimetas
    9.8 Insphero
    9.9 Cn Bio Innovations


List of Tables (42 Tables)

Table 1 Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 2 In Vitro Lung Model Market, By Region, 2016–2023 (USD Million)
Table 3 2D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 4 3D In Vitro Lung Model Market, By Type, 2016–2023 (USD Million)
Table 5 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 6 Commercialized 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 7 Commercialized 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 8 In-House 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 9 In-House 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 10 2D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 11 Drug Discovery & Toxicology Market, By Region, 2016–2023 (USD Million)
Table 12 3D Model Development Market, By Region, 2016–2023 (USD Million)
Table 13 Basic Research Market, By Region, 2016–2023 (USD Million)
Table 14 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 15 Drug Discovery & Toxicology Market, By Region, 2016–2023 (USD Million)
Table 16 Physiological Research Market, By Region, 2016–2023 (USD Million)
Table 17 Stem Cell & Regenerative Medicine Market, By Region, 2016–2023 (USD Million)
Table 18 In Vitro Lung Model Market, By Country/Region, 2016–2023 (USD Million)
Table 19 North America: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 20 North America: 2D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 21 North America: 3D Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 22 North America: Commercialized 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 23 North America: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 24 North America: 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 25 Europe: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 26 Europe: 2D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 27 Europe: 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 28 Europe: Commercialized 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 29 Europe: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 30 Europe:3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 31 Asia Pacific: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 32 Asia Pacific: 2D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 33 Asia Pacific: 3D Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 34 Asia Pacific: Commercialized 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 35 Asia Pacific: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 36 Asia Pacific: 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 37 RoW: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 38 RoW: 2D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 39 RoW: 3D Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 40 RoW: Commercialized 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)
Table 41 RoW: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 42 RoW: 3D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)

The lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in cell culture technologies, and the development of new 3D in vitro models.

The report analyzes the lung in vitro models market by type, applications, and region. Based on type, the in vitro lung model market is segmented into 2D cell models and 3D cell models. 3D cell models is further segmented into in-house and commercialized 3D models (ready-to-use). The 3D cell models segment is projected to grow at the fastest rate during the forecast period due to the rising need for efficient lung in vitro models that mimic in vivo physiology.

Based on application, the market is segmented into applications of 2D models and 3D models. Applications of 2D models include drug discovery and toxicology, 3D model development, and basic research. The drug discovery and toxicology segment is expected to hold the largest share of 2D applications in 2018. The drug discovery and toxicology applications dominated the 2D application segment owing to the flexibility and high throughput capabilities of 2D cell models. Applications of 3D models include drug discovery and toxicology, physiological research, and stem cell research & regenerative medicine. The drug discovery and toxicology segment applications of 3D lung in vitro models are expected to dominate the market in 2018. The 3D cell models provide the relevant in vivo environment and reproducibility for drug discovery and toxicology applications.

In Vitro Lung Model Market

Based on region, the in vitro lung model market is segmented into North America, Europe, Asia Pacific, and the RoW. In 2018, North America is projected to account for the largest share of the global lung in vitro models market. The development in the market in North America is driven by the flourishing research environment and abundant funding program such as increased funds for the National Institutes of Health (NIH) and increased R&D activities by biotechnology and pharmaceutical companies.

However, the dearth of skilled professionals such as researchers and technicians that are required to set up and run experiments involving complex in vitro models, is likely to be a challenge for market growth.

The major players in the lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo